A Phase 1b Platform, Interventional Biomarker Study of Targeted Add-on Advanced Therapies for the Treatment of Adult Subjects with Moderate-to-Severely Active Ulcerative Colitis (LIBRA) M26-359

Principal Investigator

Dr Alissa Walsh

Contact us

Email: emcrf@ouh.nhs.uk

IRAS number

1014448